Timely and optimal treatment of patients with STEMI

Nature Reviews Cardiology

Volumn 10, Issue 1, 2013, Pages 41-48

  Lassen, Jens F ^a   Bøtker, Hans E ^a   Terkelsen, Christian J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYSIS; HEALTH CARE SYSTEM; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPERFUSION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY DELAY;

EMERGENCY MEDICAL SERVICES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; TRIAGE;

EID: 84871809573     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.156     Document Type: Review

References (64)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1, 397-402 (1986).
2. Dalby, M., Bouzamondo, A., Lechat, P. & Montalescot, G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108, 1809-1814 (2003). (Pubitemid 37296089)
3. Levine, G. N. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J. Am. Coll. Cardiol. 58, e44-e122 (2011).
4. Authors/Task Force Members et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur. Heart J. 33, 2569-2619 (2012).
5. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) et al. Guidelines on myocardial revascularization. Eur. Heart J. 31, 2501-2555 (2010).
6. Zijlstra, F. et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur. Heart J. 23, 550-557 (2002). (Pubitemid 35192202)
7. Cannon, C. P. et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283, 2941-2947 (2000). (Pubitemid 30414505)
8. Ellis, S. G. et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med. 358, 2205-2217 (2008). (Pubitemid 351724450)
9. Dudek, D., Rakowski, T., Dziewierz, A. & Mielecki, W. Time delay in primary angioplasty: how relevant is it? Heart 93, 1164-1166 (2007). (Pubitemid 47492889)
10. De Luca, G. et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J. Am. Coll. Cardiol. 42, 991-997 (2003). (Pubitemid 37108581)
11. Gersh, B. J., Stone, G. W., White, H. D. & Holmes, D. R. Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293, 979-986 (2005). (Pubitemid 40271130)
12. Antman, E. M. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction\executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J. Am. Coll. Cardiol. 44, 671-719 (2004).
13. Kiernan, T. J., Ting, H. H. & Gersh, B. J. Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls. Eur. Heart J. 28, 1545-1553 (2007). (Pubitemid 47232251)
14. Huber, K. et al. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur. Heart J. 26, 2063-2074 (2005). (Pubitemid 41435730)
15. Boersma, E. & Primary Coronary Angioplasty vs. Thrombolysis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur. Heart J. 27, 779-788 (2006).
16. Schomig, A. et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293, 2865-2872 (2005). (Pubitemid 41029140)
17. Löwel, H., Lewis, M. & Hörmann, A. Prognostic significance of prehospital phase in acute myocardial infarct. Results of the Augsburg Myocardial Infarct Registry, 1985-1988 [German]. Dtsch Med. Wochenschr. 116, 729-733 (1991).
18. De Luca, G., Suryapranata, H., Ottervanger, J. P. & Antman, E. M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109, 1223-1225 (2004). (Pubitemid 38372780)
19. Terkelsen, C. J. et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 304, 763-771 (2010).
20. Terkelsen, C. J. et al. Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data. Ann. Intern. Med. 155, 361-367 (2011).
21. Hedges, J. R. et al. Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group. Acad. Emerg. Med. 7, 862-872 (2000). (Pubitemid 30626281)
22. Blohm, M. B., Hartford, M., Karlson, B. W., Luepker, R. V. & Herlitz, J. An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. Heart 76, 430-434 (1996). (Pubitemid 26390801)
23. Morrison, L. J., Verbeek, P. R., McDonald, A. C., Sawadsky, B. V. & Cook, D. J. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 283, 2686-2692 (2000). (Pubitemid 30337331)
24. Boersma, E., Maas, A. C., Deckers, J. W. & Simoons, M. L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348, 771-775 (1996). (Pubitemid 26308479)
25. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N. Engl. J. Med. 329, 383-389 (1993).
26. Pinto, D. S. et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 114, 2019-2025 (2006). (Pubitemid 44706877)
27. Nallamothu, B. K. & Bates, E. R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am. J. Cardiol. 92, 824-826 (2003). (Pubitemid 37163578)
28. Silber, S. et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 26, 804-847 (2005).
29. Widimsky, P. et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur. Heart J. 21, 823-831 (2000). (Pubitemid 30240769)
30. Widimsky, P. et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial\PRAGUE-2. Eur. Heart J. 24, 94-104 (2003). (Pubitemid 36109551)
31. Ribichini, F. et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J. Am. Coll. Cardiol. 32, 1687-1694 (1998). (Pubitemid 28545209)
32. Vermeer, F. et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 82, 426-431 (1999). (Pubitemid 29475199)
33. Garcia, E. et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J. Am. Coll. Cardiol. 33, 605-611 (1999).
34. Gibbons, R. J. et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N. Engl. J. Med. 328, 685-691 (1993). (Pubitemid 23073370)
35. Terkelsen, C. J. et al. Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart 95, 362-369 (2009).
36. Pinto, D. S. et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 124, 2512-2521 (2011).
37. Luepker, R. V. et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) trial. JAMA 284, 60-67 (2000). (Pubitemid 30445662)
38. Prasad, N., Wright, A., Hogg, K. J. & Dunn, F. G. Direct admission to the coronary care unit by the ambulance service for patients with suspected myocardial infarction. Heart 78, 462-464 (1997). (Pubitemid 27515105)
39. Hutchings, C. B. et al. Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care: which mode is quicker? Am. Heart J. 147, 35-41 (2004). (Pubitemid 38037394)
40. Grim, P. et al. Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital. Am. J. Cardiol. 60, 715-720 (1987). (Pubitemid 17154624)
41. Wall, T. et al. Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction. N. C. Med. J. 61, 104-108 (2000).
42. Terkelsen, C. J. et al. Telemedicine used for remote prehospital diagnosing in patients suspected of acute myocardial infarction. J. Intern. Med. 252, 412-420 (2002). (Pubitemid 36706572)
43. Terkelsen, C. J. et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. Eur. Heart J. 26, 770-777 (2005). (Pubitemid 40547079)
44. Andersen, H. R. et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N. Engl. J. Med. 349, 733-742 (2003). (Pubitemid 37010777)
45. Terkelsen, C. J. et al. Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction. Circ. Cardiovasc. Interv. 4, 570-576 (2011).
46. Magid, D. J. et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 294, 803-812 (2005). (Pubitemid 41175723)
47. Kuwabara, H., Fushimi, K. & Matsuda, S. Relationship between hospital volume and outcomes following primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ. J. 75, 1107-1112 (2011).
48. West, R. M. et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur. Heart J. 32, 706-711 (2011).
49. Navarese, E. P. et al. Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter? J. Thromb. Thrombolysis 32, 223-231 (2011).
50. Bradley, E. H. et al. Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Am. Heart J. 151, 1281-1287 (2006). (Pubitemid 43884810)
51. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N. Engl. J. Med. 320, 618-627 (1989).
52. Le May, M. R. et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J. Am. Coll. Cardiol. 46, 417-424 (2005). (Pubitemid 41040280)
53. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367, 569-578 (2006).
54. Fernandez-Aviles, F. et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur. Heart J. 28, 949-960 (2007). (Pubitemid 47343896)
55. Cantor, W. J. et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N. Engl. J. Med. 360, 2705-2718 (2009).
56. Armstrong, P. W. et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. Am. Heart J. 160, 30-35.e1 (2010).
57. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2, 349-360 (1988).
58. Chen, Z. M. et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366, 1607-1621 (2005).
59. Montalescot, G. et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373, 723-731 (2009).
60. Steg, P. G. et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 122, 2131-2141 (2010).
61. Ellis, S. G. et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med. 358, 2205-2217 (2008). (Pubitemid 351724450)
62. Danchin, N. et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on ~acute ST-elevation myocardial infarction (FAST-MI). Circulation 118, 268-276 (2008).
63. Stenestrand, U., Lindback, J., Wallentin, L. & RIKS-HIA Registry. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 296, 1749-1756 (2006). (Pubitemid 44547795)
64. Kalla, K. et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 113, 2398-2405 (2006). (Pubitemid 43948047)